Abstract
New anti-Helicobacter pylori (H. pylori) agents endowed with H2-antagonists properties were obtained by combining the lamtidine derived pharmacophoric group with the antibiotic calvatic acid. All the compounds were tested for their irreversible H2-antagonist properties and for their ability to inhibit 20 H. pylori strains, two of them metronidazole resistant. The most active derivative (compound 4) displayed antimicrobial activity similar to metronidazole.
| Original language | English |
|---|---|
| Pages (from-to) | 403-406 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 11 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 12 Feb 2001 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Anti-Helicobacter pylori agents endowed with H2-antagonist properties'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver